Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression

ClinicalTrials.gov ID: NCT01246908

Public ClinicalTrials.gov record NCT01246908. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 12:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Assessment of the Efficacy, Safety and Tolerability of CX157 Modified Release Tablet, 125 mg Twice Per Day in Subjects With Treatment Resistant Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if CX157 is effective and safe in patients with treatment of treatment resistant depression over six weeks of treatment.

Study identification

NCT ID
NCT01246908
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CeNeRx BioPharma Inc.
Industry
Enrollment
360 participants

Conditions and interventions

Eligibility (public fields only)

Age range
20 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2010 (Type not available)
Primary completion
May 2012 (Actual)
Completion
May 2012 (Actual)
Last update posted
Jul 10, 2012

2010 – 2012

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Synergy Escondido Escondido California 92025 —
Synergy Clinical Research Center National City California 91950 —
Excell Research Oceanside California 92056 —
Pacific Clinical Research Orange California 92868 —
Gulfcoast Clinical Research Center Fort Myers Florida 33912 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32216 —
The Segal Institute of Clinical Research North Miami Florida 33161 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32806 —
University of South Florida College of Medicine Psychiatry Center Tampa Florida 33163 —
Stedman Clinical Trials Tampa Florida 33613 —
Kolin Research Group Winter Park Florida 32789 —
Atlanta Institute of Medicine and Research Atlanta Georgia 30328 —
Nathan Shapira, MD, Ph.D Smyrna Georgia 30080 —
McLean Hospital Belmont Massachusetts 02478 —
AccelRx Research Fall River Massachusetts 02721 —
Eastside Comprehensive Medical Center New York New York 10021 —
Richard H. Weisler, M.D. and Associates Raleigh North Carolina 27609 —
NorthCoast Clinical Trials, Inc. Beachwood Ohio 44122 —
Patient Priority Clinical Sites, LLC Cincinnati Ohio 45215 —
North Star Medical Research, LLC Middleburg Heights Ohio 44130 —
Oregon Center for Clinical Investigations, Inc Portland Oregon 97210 —
Summitt Research Network (Oregon) Portland Oregon 97210 —
Introspect of Buxmont, Ltd Colmar Pennsylvania 18915 —
Clinical Neurosciences Solutions, Inc. Memphis Tennessee 38119 —
Community Clinical Research, Inc. Austin Texas 78754 —
FutureSearch Trials of Dallas Dallas Texas 75231 —
Radiant Research Murray Utah 84123 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Summit Research Network (Seattle) LLC Seattle Washington 98104 —
Northbrooke Research Center Deer Brown Wisconsin 53223 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01246908, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 10, 2012 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01246908 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →